|
gptkbp:instanceOf
|
patent
|
|
gptkbp:abstract
|
The invention provides methods for treating cancer.
|
|
gptkbp:applicationNumber
|
10/703,052
|
|
gptkbp:applicationType
|
utility
|
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
|
gptkbp:claims
|
20
|
|
gptkbp:contains
|
active pharmaceutical ingredient
|
|
gptkbp:description
|
novel therapeutic methods
|
|
gptkbp:examiner
|
Jane_Smith
|
|
gptkbp:expirationDate
|
March 31, 2023
|
|
gptkbp:fieldOfInvention
|
oncology
|
|
gptkbp:fieldOfUse
|
pharmaceuticals
|
|
gptkbp:hasCitations
|
gptkb:US_5,678,901_A
|
|
gptkbp:hasCollaboratedWith
|
research institutions
research projects
|
|
gptkbp:hasFieldOfUse
|
medical research
|
|
gptkbp:hasFilm
|
anti-tumor activity
|
|
gptkbp:hasPersonnel
|
exclusive license
|
|
gptkbp:hasPublications
|
gptkb:US_2004/0123456_A1
|
|
gptkbp:hasResearchInterest
|
biotechnology
clinical trials
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,073 C61
|
|
gptkbp:internationalClassification
|
A61K 31/00
|
|
gptkbp:inventor
|
gptkb:John_Doe
|
|
gptkbp:isActiveIn
|
scientific reviews
|
|
gptkbp:isAssociatedWith
|
cancer research
cancer immunotherapy
|
|
gptkbp:isCitedBy
|
gptkb:US_7,890,123_B1
oncology studies
|
|
gptkbp:isCitedIn
|
patent litigation
|
|
gptkbp:isDocumentedIn
|
patent databases
|
|
gptkbp:isEvaluatedBy
|
safety and efficacy
|
|
gptkbp:isExaminedBy
|
patent examiner
|
|
gptkbp:isFiledIn
|
gptkb:United_States
|
|
gptkbp:isFiledUnder
|
patent law
|
|
gptkbp:isIncorporatedIn
|
clinical guidelines
|
|
gptkbp:isPartOf
|
drug development
Phase II trials
patent family
Bristol-Myers_Squibb_patents
|
|
gptkbp:isPublishedIn
|
scientific journals
USPTO database
|
|
gptkbp:isRecognizedBy
|
medical community
|
|
gptkbp:isReferencedBy
|
scientific literature
|
|
gptkbp:isReferencedIn
|
academic papers
|
|
gptkbp:isRelatedTo
|
immunotherapy
|
|
gptkbp:isSubjectTo
|
patent law
|
|
gptkbp:issuedBy
|
gptkb:United_States_Patent_and_Trademark_Office
|
|
gptkbp:issuedOn
|
September 7, 2004
|
|
gptkbp:isSupportedBy
|
research funding
NIH_funding
|
|
gptkbp:isTrainedIn
|
preclinical trials
|
|
gptkbp:isUsedFor
|
treating solid tumors
|
|
gptkbp:isUtilizedIn
|
clinical studies
therapeutic applications
patent portfolios
|
|
gptkbp:isVisitedBy
|
gptkb:Bristol-Myers_Squibb_Company
oncology treatments
|
|
gptkbp:legalStatus
|
patent granted
|
|
gptkbp:priorityDate
|
March 31, 2003
|
|
gptkbp:relatedPatent
|
gptkb:US_6,123,456_A
|
|
gptkbp:relatedTo
|
cancer treatment
|
|
gptkbp:status
|
active
|
|
gptkbp:title
|
Methods for treating cancer
|